Keyphrases
Acute Kidney Injury
100%
Cardiac Surgery
39%
Confidence Interval
35%
Chronic Kidney Disease
30%
Kidney Injury molecule-1 (KIM-1)
28%
Urinary Biomarkers
21%
Diabetic Kidney Disease
20%
Estimated Glomerular Filtration Rate
18%
Plasma Biomarkers
16%
TNF Receptor 1 (TNFR1)
15%
Hospitalization
15%
Kidney Disease Progression
15%
High Risk
14%
Meta-analysis
13%
Kidney
13%
COVID-19
13%
Systematic Meta-analysis
12%
Acute Decompensated Heart Failure
12%
Serum Creatinine
12%
Kidney Disease
11%
Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL)
11%
Hospitalized Patients
11%
Dialysis
10%
Interleukin-18 (IL-18)
10%
TNF Receptor 2 (TNFR2)
10%
Renal Function Improvement
10%
Kidney Function
10%
Kidney Outcomes
10%
Adjusted Hazard Ratio
10%
Albumin-to-creatinine Ratio
9%
Randomized Controlled Trial
9%
Monocyte Chemoattractant protein-1 (MCP-1)
8%
Renal Disease
7%
Critically Ill Patients
7%
Clinical Outcomes
7%
Creatinine
7%
Serial Assessment
7%
Adjusted Odds Ratio
7%
Clinical Trials
7%
Postoperative Acute Kidney Injury
7%
Operative
7%
Proteinuria
7%
Odds Ratio
7%
United States
6%
Kidney Injury
6%
Multicenter Cohort Study
6%
Pediatric Cardiac Surgery
6%
Renal Outcome
6%
Cystatin C (Cys C)
6%
Albuminuria
6%
Medicine and Dentistry
Acute Kidney Injury
82%
Biological Marker
58%
Heart Surgery
34%
Kidney Function
29%
Chronic Kidney Disease
29%
Acute Renal Failure
27%
Creatinine
22%
Urinary System
18%
Glomerular Filtration Rate
16%
Systematic Review
14%
Diabetic Nephropathy
14%
COVID-19
13%
Nephropathy
12%
Kidney Injury
11%
Cohort Analysis
10%
Disease Exacerbation
10%
Congestive Heart Failure
10%
Odds Ratio
10%
Cardiovascular System
10%
Hazard Ratio
9%
Injury
9%
Acute Decompensated Heart Failure
9%
Kidney Injury Molecule 1
8%
Proteinuria
8%
Meta-Analysis
8%
Neutrophil Gelatinase Associated Lipocalin
7%
Pediatrics
7%
Interleukin 18
7%
Randomized Controlled Trial
6%
Renal Failure
6%
End Stage Renal Disease
6%
Clinical Trial
6%
Diabetes
5%
Renal Replacement Therapy
5%
Transplantation
5%
Sequela
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Kidney Failure
83%
Biological Marker
58%
Chronic Kidney Failure
30%
Creatinine
25%
Congestive Heart Failure
14%
Kidney Disease
14%
Cohort Study
14%
Diabetic Nephropathy
11%
Kidney Injury Molecule 1
11%
Kidney Injury
10%
Disease Exacerbation
9%
Neutrophil Gelatinase Associated Lipocalin
9%
Acute Heart Failure
8%
Inflammation
8%
Randomized Controlled Trial
7%
Disease
7%
Interleukin 18
7%
Kidney Failure
6%
Proteinuria
6%
Replacement Therapy
6%
Injury
6%
Comorbidity
6%
Coronavirinae
5%
Adverse Outcome
5%
HIV
5%
End Stage Renal Disease
5%
Cardiovascular Disease
5%
Non Insulin Dependent Diabetes Mellitus
5%
Cystatin C
5%
Tumor Necrosis Factor Receptor 1
5%